Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kymera Therapeutics
Kymera Therapeutics
Why Shares of Kymera Therapeutics Jumped on Tuesday
Motley Fool
Tue, 10/3/23 - 07:26 pm
Kymera Therapeutics
Kymera receives FDA fast track designation for KT-333
Pharmaceutical Business Review
Tue, 09/19/23 - 10:42 am
Kymera Therapeutics
fast track
FDA< KT-333
cutaneous T-cell lymphoma
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
FDA Review: Abiomed, Mallinckrodt, Aro and More
BioSpace
Sun, 09/18/22 - 10:42 pm
FDA
devices
Medtech
Abiomed
cardiogenic shock
clinical trials
Impella
Mallinckrodt
Kymera Therapeutics
Aro Biotherapeutics
Kymera opens up $150M PIPE financing, thanks to unexpected offer from investors
Endpoints
Sun, 08/21/22 - 09:23 pm
Kymera Therapeutics
PIPE financing
funding
Biotech earnings arrive after dreadful 6 months, but upcoming readouts offer hope to analysts
Fierce Biotech
Mon, 07/18/22 - 10:08 am
earnings
biotech
Kymera Therapeutics
BioNTech
Seagen
Kymera Therapeutics, fresh off a $2B Sanofi biobucks pact, guns for an IPO
Fierce Biotech
Mon, 08/3/20 - 10:19 am
Kymera Therapeutics
IPOs
Sanofi
protein degradation